Page 48 - Michael Erman News Today

By Michael Erman NEW YORK (Reuters) - The U.S. Senate Finance Committee is widening its investigation into the tax practices of U.S. drugmakers to inc...

(Reuters) - The United States declared the monkeypox outbreak a public health emergency, a move that may increase health agency access to funds and al...

(Reuters) - The United States declared the monkeypox outbreak a public health emergency, a move that may increase health agency access to funds and allow the government new avenues for increasing production and use of existing vaccines.

(Reuters) - Moderna Inc on Wednesday retained its full-year sales outlook for COVID-19 shot at $21 billion due to decreasing orders from low- and midd...

By Michael Erman and Manas Mishra

LONDON, Aug 3 (Reuters) - The European Medicines Agency (EMA) is recommending Novavax's COVID-19 vaccine carry a warning of the possibility of two types of heart inflammation, an added burden for a shot that has so far failed to win wide uptake.

By Natalie Grover and Ludwig Burger

By Michael Erman (Reuters) - Drugmaker Merck & Co avoided billions of dollars of U.S. taxes in recent years on its top-selling cancer drug Keytruda by...

(Reuters) - Vaccine maker Novavax on Tuesday said that the U.S. Food and Drug Administration had cleared a lot of its COVID vaccine for release in the...

By Mrinalika Roy (Reuters) -Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted unanimously to recommend use of Nov...